These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1136340)

  • 21. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA; McCune WJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [2 cases of systemic lupus erythematosus treated with immunosuppressive agents].
    Laugier P; Hunziker N
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):410-1. PubMed ID: 5510737
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulation of experimental systemic lupus erythematosus.
    Mozes E; Segal R; Sthoeger Z; Dayan M; Zinger H; Kohn LD; Singer DS
    Isr J Med Sci; 1996 Jan; 32(1):19-21. PubMed ID: 8550341
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunosuppressive therapy of systemic lupus erythematosus].
    Miescher PA; Lambert PH
    Ther Umsch; 1971 Sep; 28(9):579-85. PubMed ID: 5122520
    [No Abstract]   [Full Text] [Related]  

  • 25. Methotrexate treatment in cutaneous lupus erythematosus: subcutaneous application is as effective as intravenous administration.
    Huber A; Tüting T; Bauer R; Bieber T; Wenzel J
    Br J Dermatol; 2006 Oct; 155(4):861-2. PubMed ID: 16965455
    [No Abstract]   [Full Text] [Related]  

  • 26. [DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)].
    Huber C; Günther R; Michlmayr G; Huber H; Braunsteiner H
    Wien Klin Wochenschr; 1973 Feb; 85(6):92-5. PubMed ID: 4155172
    [No Abstract]   [Full Text] [Related]  

  • 27. Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide.
    Barile L; Lavalle C
    J Rheumatol; 1992 Mar; 19(3):370-2. PubMed ID: 1578449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated nodulosis during methotrexate therapy in a patient with systemic lupus erythematosus and Jaccoud's arthropathy.
    Rivero MG; Salvatore AJ; Gómez-Puerta JA; Mascaró JM; Cañete JD; Muñoz-Gómez J; Sanmartí R
    Rheumatology (Oxford); 2004 Dec; 43(12):1587-8. PubMed ID: 15564638
    [No Abstract]   [Full Text] [Related]  

  • 29. Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate.
    Valesini G; Priori R; Francia A; Balestrieri G; Tincani A; Airo P; Cattaneo R; Zambruni A; Troianello B; Chofflon M
    Springer Semin Immunopathol; 1994; 16(2-3):313-21. PubMed ID: 7716711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylprednisolone pulse therapy as primary management strategy in systemic lupus erythematosus.
    Gallo M; La Montagna G; Chianese U; Tirri R; Tirri G
    J Rheumatol; 1992 Aug; 19(8):1322-3. PubMed ID: 1404179
    [No Abstract]   [Full Text] [Related]  

  • 31. Response to intravenous cyclophosphamide treatment in lupus myelopathy.
    Berlanga B; Rubio FR; Moga I; Pac V
    J Rheumatol; 1992 May; 19(5):829-30. PubMed ID: 1613722
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of cyclosporine in the treatment of autoimmune disorders.
    Favre H; Miescher PA; Lemoine R
    Transplant Proc; 1994 Dec; 26(6):3194-6. PubMed ID: 7998112
    [No Abstract]   [Full Text] [Related]  

  • 33. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A; Ballardini G; Viola S; Villa I; Ruperto N; Martini A
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treatment of disseminated lupus erythematosus. So-called immunosuppressive drugs].
    Clément F
    Schweiz Med Wochenschr; 1970 Feb; 100(7):333-5. PubMed ID: 4189917
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect and limitation of intravenous methylprednisolone pulse therapy in the long-term follow-up of childhood systemic lupus erythematosus].
    Yokota S; Shimizu H; Aihara Y; Mitsuda T; Ibe M; Kuriyama T; Mori T; Kosuge K
    Ryumachi; 1992 Jun; 32(3):215-22. PubMed ID: 1523523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The long-term parenteral use of cyclophosphane in treating patients with systemic lupus erythematosus and central nervous system involvement].
    Ivanova MM; Bliziuk OI; Travkina IV
    Ter Arkh; 1995; 67(5):45-7. PubMed ID: 7638778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic lupus erythematosus.
    Madhok R; Wu O
    Am Fam Physician; 2007 Nov; 76(9):1351-3. PubMed ID: 18019880
    [No Abstract]   [Full Text] [Related]  

  • 39. What's new in the treatment of pediatric SLE.
    Silverman E
    J Rheumatol; 1996 Sep; 23(9):1657-60. PubMed ID: 8877943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR; Sato EI
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.